Cancer Specialists Wield Breakthrough Alternatives in Battle with Mesothelioma, despite the Fact that Prognosis Looks Bleak
Oncologists decide what type of treatment to pursue with a patient. There are many options. There are no one size fits all treatment course for malignant mesothelioma cancer patients. Mesotheliomas lack of agreed-upon treatment is due to low a treatment success rate, rareness, a high mortality rate and a small number of studies providing meaningful stats.
While prospects for patients with mesothelioma have been bleak, doctors have been making progress. Customary treatments for cancer are surgery (removing the tumor and the tissue that surrounds it), chemotherapy (poisoning cancerous cells) and radiation (killing cancer cells with radiation) Each one of these methods have problems. Mesothelioma patients treated with traditional radiation therapy have not responded well to it. In hopes to lessen damage to healthy tissue, researches are studying ways to aim radiation right at the tumor.
The mesothelial tissue around the tumor is removed by surgery. This surgery is extensive and it is not clear how much the patient benefits. The usual chemotherapy cocktails effective on other cancers are not effective on mesothelioma, and combinations of chemotherapy agents have been tried, but without much success. Like radiation, researchers are focusing their work on controlling the physical location of the treatment with an emphasis on the pleural cavity.
Many advanced techniques in cancer treatment are tried on mesothelioma patients because of its high fatality rate. These techniques include a biologic therapy called the agent interleukin 2 and anti-angiogenesis drugs like thalidomide. Pemetrexed (Alimta) is a new drug that has shown results in extending life.
Before acting, oncologists review the stage of mesothelioma, position of the tumor, and age and health status of the patient. Two exotic ways of attacking mesothelioma are gene therapy and photodynamic therapy. Mesothelioma patients sometimes become involved in clinical trials in this area, and see benefits.
